Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Share Resize Pfizer and its partner plan to seek regulatory approval for a Lyme disease vaccine. Photo: Arun Sankar/Agence France-Presse/Getty Images Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial - MarketWatch Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial Valneva shares slump as the primary endpoint didn't meet statistical significance Published: March 23, 2026 at 7:07 a.m. ET About the Author Steve Goldstein Steven Go ...